Early onset torsion dystonia is an autosomal dominant movement disorder of variable penetrance caused by a glutamic acid, i.e. ΔE, deletion in DYT1, encoding the protein TorsinA. Genetic and structural data implicate basal ganglia dysfunction in dystonia. TorsinA, however, is diffusely expressed, and therefore the primary source of dysfunction may be obscured in pan-neuronal transgenic mouse models. We utilized the tyrosine hydroxylase (TH) promoter to direct transgene expression specifically to dopaminergic neurons of the midbrain to identify cell-autonomous abnormalities. Expression of both the human wild type (hTorsinA) and mutant (ΔE-hTorsinA) protein resulted in alterations of dopamine release as detected by microdialysis and fast cycle voltammetry. Motor abnormalities detected in these mice mimicked those noted in transgenic mice with pan-neuronal transgene expression. The locomotor response to cocaine in both TH-hTorsinA and TH-ΔE-hTorsinA, in the face of abnormal extracellular DA levels relative to non-transgenic mice, suggests compensatory, post-synaptic alterations in striatal DA transmission. This is the first cell-subtype-specific DYT1 transgenic mouse that can serve to differentiate between primary and secondary changes in dystonia, thereby helping to target disease therapies.
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Introduction
Early onset torsion dystonia (EOTD) is an autosomal dominant movement disorder of variable penetrance due to a GAG (glutamic acid, i.e. ΔE) deletion in DYT1, the gene that encodes the protein TorsinA (Ozelius et al., 1997) . As TorsinA expression is diffused within the central nervous system and peripheral organs (Ozelius et al., 1997) , the source of primary dysfunction is obscured. Implicating dysfunction within the basal ganglia, however, is the fact that numerous clinical conditions presenting during the pediatric period with motor manifestations similar to EOTD, are associated with damage or degeneration within these nuclei. Basal ganglia dysfunction has been examined in several mouse models of EOTD (reviewed in Granata et al. (2009)), but data interpretation has been complicated by the widespread expression, knock-in, knock-down, or knock-out of the gene, making it difficult to determine the effects of the mutated protein on specific cell populations within the complex basal ganglia circuitry.
A key component of basal ganglia circuitry is the nigrostriatal dopamine (DA) pathway, which projects from the substantia nigra pars compacta (SNpc) to the dorsal striatum. TorsinA is expressed in SNpc DA neurons and their axonal projections in the striatum, but its expression is not enriched in those somata (Shashidharan et al., 2000a,b; Konakova and Pulst, 2001; Augood et al., 2003) . TorsinA is a member of the AAA+ ATPase family of proteins, which are chaperones that interact with, and alter the conformation of, other proteins (Breakefield et al. (2001 (Breakefield et al. ( , 2008 and Granata et al. (2009) for review). TorsinA interactors include snapin, kinesin light chain 1, nuclear envelope protein LAP1, endoplasmic reticulum LULL1, and nesprins, suggesting multiple roles for TorsinA, such as vesicle recycling, neurotransmitter release and re-uptake, protein processing, neuronal protection, cell adhesion, neurite extension, nuclear Neurobiology of Disease 39 (2010) 318-326 
